JAK2 and lung carcinoma: Finally, BCAA metabolism has recently been associated with tyrosine kinase inhibitor resistance in lung cancer, suggesting such metabolic reprogramming may also contribute to the inefficacy or resistance to JAK2 inhibition (115).